Full year 2025 financial guidance excludes any potential share repurchase or additional M&A activity. CEO Dr. Steve Cutler commented, "ICON continues ... opportunities to further solidify our ...

Full year 2025 financial guidance excludes any potential ... in 55 countries as at September 30, 2024. For further information about ICON, visit: www.iconplc.com.

ICON (NASDAQ:ICLR) stock fell 8% early Tuesday after it issued financial guidance for 2025. The clinical research organization said that it expects to report 2025 revenue of $8.05B to $8.650B ...

(RTTNews) - ICON Plc (ICLR), healthcare intelligence and clinical research company, on Tuesday reaffirmed its annual guidance. In addition, the firm has initiated outlook for the full-year 2025.